Jiangsu Lianhuan Pharmaceutical (600513.SH) terminates the company's issuance of new shares through a simplified procedure in 2024.

Jiangsu Lianhuan Pharmaceutical (600513.SH) announced that since the company's announcement of issuing shares to specific targets through a simplified process in 2024, the company's board of directors, management, and intermediary institutions have been actively advancing various work. Taking into account the current market situation, as well as the company's actual situation and development plan, among other factors, and after thorough communication and careful analysis with relevant parties to protect the interests of the company and all shareholders, it has been decided to terminate the issuance of shares to specific targets through a simplified process in 2024.